TSO3 Appoints Dr. Bradley J. Catalone as Chief Science Officer

Monday, September 25, 2017

 

Quebec City, Canada and Myrtle Beach, United States, September 25, 2017 – TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, today announced that Dr. Bradley J. Catalone MBA, Ph.D. has joined TSO3 as its Chief Science Officer. 

Dr. Catalone has extensive knowledge of medical devices and the sterilization industry, having held significant roles within Olympus Corporation of the Americas Inc., including as Infection Control Manager, Director of Research, as well as Director of Clinical Affairs.  Most recently, Dr. Catalone held the position of Vice President of Laboratory Services at Alcami Corporation with responsibility for drug development and analytical testing services.  Dr. Catalone holds a Ph.D. in Microbiology and Immunology from Penn State College of Medicine, Hershey, PA and an MBA. in Business Administration from the Pennsylvania State University.

 “I am very pleased to welcome Brad to the TSO3 organization” stated R.M. (Ric) Rumble TSO3’s President and CEO.  “Brad brings fifteen years of professional experience with increased accountability and responsibility within our industry. He is a strong advocate for patient safety and has directly championed improvements in device reprocessing.”

As Chief Science Officer, Dr. Catalone will oversee all scientific operations to ensure completion of key development milestones and targeted projects.  Dr. Catalone will be responsible of relationships with external stakeholders, including regulatory agencies, leading scientific institutions and standard-setting organizations.

About TSO3

Founded in 1998, TSO3's activities encompass the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment that offer an advantageous replacement solution to other low temperature sterilization processes currently used in hospitals. TSO3 also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes.

For more information about TSO3, visit the Company's website at www.tso3.com.        

- 30 -

Source: TSO3 Inc.

For further information

Company Contacts:

TSO3 Inc., R.M. (Ric) Rumble, President and CEO, Tel: 418 651-0003, Email: info@tso3.com                    

TSO3 Inc., Glen Kayll, CFO, Tel: 418 651-0003, Email: info@tso3.com

Investor Relations:

Gilmartin Group, Greg Chodaczek, Tel: 610-368-6505, Email: Greg@gilmartinir.com

Renmark Financial Communications Inc., Barry Mire, Tel: 416 644-2020 or 514 939-3989, Email: bmire@renmarkfinancial.com

 

 

 

<  Back to News & Events